Low Apgar Score and Risk of Neonatal Mortality among Infants with Birth Defects

Abstract

Objective

The Apgar score is a clinical tool to assess newborn health at delivery and has shown utility in predicting neonatal mortality in the general population, but its predictive ability in neonates with birth defects remains unexplored. As such, we aimed to investigate the performance of the 5-minute Apgar score in predicting neonatal mortality among neonates with a spectrum of major birth defects.

Study Design

Data for neonates with birth defects born between 1999 and 2017 were obtained from the Texas Birth Defect Registry. We generated receiver operating characteristic curves and corresponding area under the curve (AUC) values for neonatal mortality (death within the first 28 days of life) by 5-minute Apgar score (<7 vs. ≥7) to measure discrimination capacity. We performed secondary analyses to determine the predictive ability of the Apgar score: (1) among infants with an isolated birth defect and (2) separately in preterm and term neonates.

Results

Low Apgar score yielded substantial predictive ability for neonatal mortality, with 25 out of 26 AUC values > 0.70 across a spectrum of defect categories. High predictive ability was consistent among neonates with isolated defects, and preterm and term neonates.

Conclusion

The Apgar score is likely useful for predicting neonatal mortality among most neonates with birth defects. Despite small sample sizes limiting some secondary analyses, the findings emphasize the potential continued use of the Apgar score as a rapid clinical assessment tool for newborns with birth defects. Continued research may refine the Apgar score's application in this important population, both in clinical practice and population health research.

Key Points

• Predictive models suggest the 5-minute Apgar score (<7) is predictive of neonatal mortality.

• Consistent results were observed across spectrum of birth defect categories.

• Secondary analyses (e.g., preterm infants) yielded similarly consistent results.

Keywords

birth defects - Apgar score - neonates - neonatal mortality - prediction model

Publikationsverlauf

Eingereicht: 21. Juni 2024

Angenommen: 25. Oktober 2024

Artikel online veröffentlicht:
25. November 2024

• References

• 1 Ely DM, Driscoll AK. Infant mortality in the United States, 2021: data from the period linked birth/infant death file. National vital statistics reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics. Natl Vital Stat Syst 2023; 72 (11) 1-19
• 2 Benjamin RH, Salemi JL, Canfield MA. et al. Causes of neonatal and postneonatal death among infants with birth defects in Texas. Birth Defects Res 2021; 113 (09) 665-675
• 3 Apgar V. A proposal for a new method of evaluation of the newborn infant. Curr Res Anest Anal 1953; 32 (04) 260-267
• 4 American Academy of Pediatrics Committee on Fetus and Newborn; American College of Obstetricians and Gynecologists Committee on Obstetric Practice;. Watterberg KL, Aucott S, Benitz WE. The Apgar Score. Pediatrics 2015; 136 (04) 819-822
• 5 Razaz N, Norman M, Alfvén T, Cnattingius S. Low Apgar score and asphyxia complications at birth and risk of longer-term cardiovascular disease: a nationwide population-based study of term infants. Lancet Reg Health Eur 2022; 24: 100532
• 6 Persson M, Razaz N, Tedroff K, Joseph KS, Cnattingius S. Five and 10 minute Apgar scores and risks of cerebral palsy and epilepsy: population based cohort study in Sweden. BMJ 2018; 360: k207
• 7 Li F, Wu T, Lei X, Zhang H, Mao M, Zhang J. The Apgar score and infant mortality. PLoS One 2013; 8 (07) e69072
• 8 Iliodromiti S, Mackay DF, Smith GCS, Pell JP, Nelson SM. Apgar score and the risk of cause-specific infant mortality: a population-based cohort study. Lancet 2014; 384 (9956) 1749-1755
• 9 Cnattingius S, Norman M, Granath F, Petersson G, Stephansson O, Frisell T. Apgar score components at 5 minutes: risks and prediction of neonatal mortality. Paediatr Perinat Epidemiol 2017; 31 (04) 328-337
• 10 Cnattingius S, Johansson S, Razaz N. Apgar score and risk of neonatal death among preterm infants. N Engl J Med 2020; 383 (01) 49-57
• 11 Al-Dewik N, Samara M, Younes S. et al. Prevalence, predictors, and outcomes of major congenital anomalies: a population-based register study. Sci Rep 2023; 13 (01) 2198
• 12 Sattolo M-L, Arbour L, Bilodeau-Bertrand M, Lee GE, Nelson C, Auger N. Association of birth defects with child mortality before age 14 years. JAMA Netw Open 2022; 5 (04) e226739-e226739
• 13 Langlois PH, Marengo L, Lupo PJ. et al. Evaluating the proportion of isolated cases among a spectrum of birth defects in a population-based registry. Birth Defects Res 2023; 115 (01) 21-25
• 14 Thomas AN, McCullough LB, Chervenak FA, Placencia FX. Evidence-based, ethically justified counseling for fetal bilateral renal agenesis. J Perinat Med 2017; 45 (05) 585-594
• 15 State and territorial exchange of vital events (STEVE). National Association for Public Health Statistics and Information Systems (NAPHSIS). Accessed February 1, 2024 at: https://www.steve2.org/#/landing
• 16 Benjamin RH, Lopez A, Mitchell LE. et al. Mortality by mode of delivery among infants with spina bifida in Texas. Birth Defects Res 2019; 111 (19) 1543-1550
• 17 Benjamin RH, Nguyen JM, Canfield MA, Shumate CJ, Agopian AJ. Survival of neonates, infants, and children with birth defects: a population-based study in Texas, 1999-2018. Lancet Reg Health Am 2023; 27: 100617
• 18 Garne E, Dolk H, Loane M. et al; EUROCAT Working Group. Paper 5: Surveillance of multiple congenital anomalies: implementation of a computer algorithm in European registers for classification of cases. Birth Defects Res A Clin Mol Teratol 2011; 91 (Suppl. 01) S44-S50
• 19 Li F, He H. Assessing the accuracy of diagnostic tests. Shanghai Jingshen Yixue 2018; 30 (03) 207-212